Latest ELEVRA LITHIUM (ASX:ELV) News

Elevra Lithium reported solid Q2 FY26 production and revenue results while progressing its North American Lithium brownfield expansion and forging strategic supply partnerships.

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Explorers led the Materials tape as fresh drill stories and new ground deals pulled buyers into small caps. Big miners still delivered, but the loudest moves came from companies offering investors a near-term catalyst.

Elevra Lithium has signed a non-binding MoU to supply up to 144,000 tonnes of spodumene concentrate annually to Mangrove Lithium, supporting a new Canadian lithium conversion facility and strengthening domestic battery material production.

Elevra Lithium Limited reported record quarterly revenue and gross profit at its North American Lithium operation, even as it navigates short-term production challenges and revises FY2026 guidance downward.

Elevra Lithium unveils a staged, accelerated expansion plan for its North American Lithium mine, aiming to increase spodumene concentrate production to 315ktpa by early 2029 while lowering operating costs.

Elevra Lithium reports a 31% surge in spodumene concentrate production for FY25, alongside significant resource expansions and a clear growth roadmap post-merger.

Elevra Lithium reports robust Q1 FY26 results with record production and a significant increase in lithium resources, advancing its brownfield expansion and multiple development projects.

Elevra Lithium has completed a transformative merger and maintained robust production at its North American Lithium operation, while unveiling a compelling expansion plan that could boost output by 55% and slash costs.